Vol. 33 (3) 2026
Evaluation of serum human galectin 3 as a marker of activity in inflammatory bowel disease in comparison to fecal calprotectin … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 65–71....
Vol. 33 (3) 2026
Tumor necrosis factor alpha-induced protein3 rs;10499194 polymorphism enhances presepsin and sCD64 accuracy in differentiating infection from rheumatoid arthritis flare … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506)...
Vol. 33 (3) 2026
Serum Sirtuin 1 as a potential indicator of disease activity and severity in systemic lupus erythematosus patients … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 36–42....
Vol. 33 (3) 2026
Association between selected immune parameters and thalassemia: An analytical study … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 27–35. www.Ejimmunology.org...
Vol. 33 (3) 2026
Study of ectodomain of type 23 collagen as a novel marker of disease activity in patients with ulcerative colitis disease … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 19–26....
Vol. 33 (3) 2026
Immune modulation and evasion by Toxoplasma gondii: Roles of IFN-g, TNF-α, IL-10, and IgM in murine infection … Original Research Article … The Egyptian Journal of Immunology E-ISSN (2090-2506) Volume 33 (3), July, 2026 Pages: 09–18. www.Ejimmunology.org...
